about
Methadone at tapered doses for the management of opioid withdrawalOpioid antagonists under heavy sedation or anaesthesia for opioid withdrawalBuprenorphine for the management of opioid withdrawalMethadone at tapered doses for the management of opioid withdrawalClinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.Behavioral arousal in response to stress and drug cue in alcohol and cocaine addicted individuals versus healthy controls.Placement matching: challenges and technical progress.The use of tramadol for acute heroin withdrawal: a comparison to clonidine.Buprenorphine retention in primary care.Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.Pharmacologic treatments for opioid dependence: detoxification and maintenance options.Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films.Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study.Characterizing opioid withdrawal during double-blind buprenorphine detoxification.A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.Gender differences in response to emotional stress: an assessment across subjective, behavioral, and physiological domains and relations to alcohol cravingInduction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.Treatment of opioid-dependent pregnant women: clinical and research issues.Heroin detoxification with buprenorphine on an inpatient psychiatric unitBrief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study.Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.Reliability and Validity Study of the Turkish Version of the Clinical Opiate Withdrawal Scale.Substance user treatment program quality: selected topics.Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women.Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement.Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.Pharmacological challenge with naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial.Reliability of sequential naloxone challenge tests.
P2860
Q24200729-7CF2ADD3-0430-45D0-8495-F26B37A2D469Q24240954-107CE86C-BE95-4C9F-8E26-E3EDB75F7342Q24246088-A2094BCD-F7D8-4756-B132-A7A7AF557FA5Q24246574-60966407-02B4-4B59-97A2-D0A16ED32AFCQ33915859-850B98F3-9073-4AD4-8FCA-83E68A56EF34Q34040286-7F802F27-BD18-4E55-A4AA-E156BD76ACD8Q34051787-D5F9F1F2-2F67-4CD3-9334-C0DC7C45799AQ34118724-71983F79-5B85-4243-81F0-D3F78CDCA267Q34544544-562438F5-36CA-40F0-A506-5B06F633C337Q34724382-9754FCB7-5DF8-4640-B5DA-739DAC442DAFQ35090939-C1A0CE76-F107-4DBF-A4B5-D1828163AE85Q35220378-D5C425B7-CA2A-4D24-89F1-0CA7D9E36ED9Q35454866-31BD981D-2715-4015-95CF-8CA2640229E7Q35575641-202DD078-7845-4C19-BCDB-E85F1C435167Q35629021-D9955C91-4220-40DE-ABBB-362958AA0804Q35660989-8028296A-1CD2-4D80-8EA0-68433B0B0673Q35936860-69B30218-B755-48B7-8203-7AF84C9F0AFBQ36021346-A466145E-D6E2-4906-B58B-11944CFFEAF4Q36953660-2E977746-6E1B-4329-8CD8-26EDEAF66773Q37067368-E5E8D903-4ECF-42F3-9903-1489F35E5886Q37076673-8F80F4A7-DF0C-4007-B3DB-7CB8331C8AF7Q37079337-EE1B885C-B001-4961-8A3F-4AA52BFE5882Q37098791-9B82E6F1-9F1F-4EC4-98A8-10780A41F662Q37414069-79BB85D4-3E51-4A7F-9C16-828D1F96D5A6Q41775207-936C8754-D6F4-43CC-85D9-21C7E24ED82FQ44103409-9AF2ACC7-BD9D-4174-87C4-3A2F9B0CDFBFQ44336832-61965324-2176-42D5-9B0B-77D51472EB5DQ44339988-41150BB3-C163-4C0D-BC6D-58DEBEADFF0CQ48505880-63247ABA-556E-44CB-8D8C-6336F28A5DCBQ50722956-854628E3-1E81-4083-AFFF-D63094C0215CQ52012693-B5BAB74F-7188-4064-BE1D-FBF5582DE46B
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Assessment of opioid dependence with naloxone.
@en
Assessment of opioid dependence with naloxone.
@nl
type
label
Assessment of opioid dependence with naloxone.
@en
Assessment of opioid dependence with naloxone.
@nl
prefLabel
Assessment of opioid dependence with naloxone.
@en
Assessment of opioid dependence with naloxone.
@nl
P2860
P1476
Assessment of opioid dependence with naloxone.
@en
P2093
P2860
P304
P356
10.1111/J.1360-0443.1988.TB03981.X
P577
1988-02-01T00:00:00Z